Previous studies have demonstrated that a missense single-nucleotide polymorphism variant (2316A>G; rs2230739) of the adenylate cyclase type IX gene was associated with bipolar disorder and affective disorder. We determined genotype and allele frequencies using a ligase detection reaction method in 315 patients with major depressive disorder and 278 unrelated, sex-matched healthy control subjects. We did not detect any statistically significant differences in genotype and allele frequencies between patients and healthy control subjects. Furthermore, we found no significant difference between genders in major depressive disorder, nor between patients and controls in the same gender. These results suggest that 2316A>G (rs2230739) may not be a risk factor for increasing susceptibility to major depressive disorder in the Chinese Han population.
INTRODUCTION
Current evidence suggests that modifications in cyclic adenosine monophosphate (cAMP) signaling are involved in the pathophysiology and treatment of depression, with alterations in cAMP signaling pathways found in postmortem studies of brains from patients with depression [1] [2] [3] [4] [5] [6] .
Adenylate cyclase (AC) is the enzyme that synthesizes cAMP from adenosine triphosphate (ATP). Regulation of intracellular cAMP concentrations is large due to modulation of AC. Previous studies have shown that AC activities are decreased in platelets and postmortem brain from patients with depression [7] [8] [9] .
There are at least nine membrane-bound isoforms of AC, which are regulated by neurotransmitters and drugs, acting via G protein-coupled receptors to modulate intracellular cAMP levels. A number of AC isoforms have been linked to development of psychiatric disorders; for example, in www.nrronline.org humans the adenylate cyclase type VII gene (ADCY7) is associated with major depressive disorder (MDD) in a sex-specific relationship. ADCY7 is also associated with depressive-like behaviors in mice [10] .
Additionally, in platelets from depressed patients, AC1, AC3 and AC8 show reduced activity [11] [12] , and AC5 is a pharmacological target for depression and anxiety disorders [13] .
Of all the isoforms, AC9 shows the most sequence divergence, and is therefore a unique member of the mammalian AC family [14] [15] .
Of particular interest is the relatively abundant expression of AC9 mRNA and protein in the hippocampus, a region important for learning and memory, and also associated with depression [16] [17] .
Furthermore, the gene for the ADCY9 subunit is located on chromosome 16p13.3, a location that shows modest linkage signals for mood disorders [18] [19] [20] [21] .
Nevertheless, there are only a few studies focusing on the function of AC9 in the etiology of MDD. Recently, a missense single-nucleotide polymorphism variant (2316A>G; rs2230739) in exon 7 (aa 772) of the human AC gene, ADCY9, was identified [22] . This single-nucleotide polymorphism has previously been associated with bipolar disorder and mood disorder [23] [24] .
In this study, we investigated the potential role of the 2316A>G polymorphism in the etiology of MDD in the Chinese Han population.
RESULTS
Quantitative analysis of subjects A total of 593 subjects (315 MDD patients and 278 healthy controls) were included in the study. Furthermore, no significant differences in allele or genotype frequencies were detected between males and females in the MDD group (genotype: χ 2 = 0.35, P = 0.84; allele: χ 2 = 0.34, P = 0.56) ( Table 2) .
Subject baseline characteristics
Genotype distributions and allele frequencies of rs2230739, between MDD and control groups from the same gender, are shown in Tables 3, 4 . We detected no significant differences in the genotype distribution or 
DISCUSSION
To our knowledge, this is the first study to examine the association between the AC9 polymorphism and MDD in a large case-control study in the Chinese Han population. The potential influence of this polymorphism on ADCY9 function has not been examined in detail, but its location within exon 7 leads to a missense mutation responsible for altering the activity of ADCY9 function, which may in turn increase susceptibility to certain psychiatric disorders. Our study failed to detect an association between this polymorphism and MDD. In contrast to our finding, there is the initial report of an association between this genetic variant and unipolar disorder in the Japanese population [24] . Toyota et al [23] confirmed that the ADCY9 gene variation had a weak association with bipolar disorder (P = 0.033 2), but did not show which genotype or allele was the risk factor for bipolar disorder. The 2316A>G allele frequency in our samples (0.43) was not the same as Toyota et al [24] (0.36). The discrepancy in allele frequencies may be partly responsible for the divergent association results. It has been suggested that focusing on specific subclinical phenotypes may increase the strength to detect genes involved in complex disorders, including affective disorders [25] [26] . Given that in the United States, the lifetime prevalence of MDD in women is approximately twice that in men [2] , we hypothesized that the ADCY9 polymorphism is associated with gender differences in MDD. Therefore, to reduce the clinical heterogeneity, we examined the patient and control subgroups according to gender. Thus, we compared genotype and allele frequencies of the ADCY9 single nucleotide polymorphism in MDD between genders but did not detect a significant relationship. Similarly, we compared genotype and allele frequencies of the ADCY9 single nucleotide polymorphism in MDD and control groups within the same gender, but again did not detect a relationship. It is not known whether these variants can alter ADCY9 function, although the substitution of isoleucine with methionine removes a bulky side chain that may change the conformation of the enzyme. Taken together, these results indicate that ADCY9 does not have a genetic influence on MDD in the Chinese Han population. Therefore, our results suggest that the influence of the 2316A>G polymorphism on major depression may be ethnically dependent. Large replication studies with different ethnic groups are needed to determine whether there are ethnic differences in the influence of the 2316A>G polymorphism on major depression. The main limitation of our study is the small sample size. It is generally accepted that case-control association studies are influenced by sample size and that small sample size can lead to false results. Another limitation of this study is that we only focused on the IX isoform of adenylate cyclase. It is possible that other isoforms of adenylate cyclase may be important in conferring susceptibility to MDD patients.
In conclusion, we report a negative association of an ADCY9 polymorphism with MDD. However, the result of our case-control gene association study should be interpreted with caution due to the study limitations discussed.
SUBJECTS AND METHODS

Design
A case-control human gene polymorphism association study.
Time and setting
The study was performed in the Laboratory of Zhengzhou University Medical Center, China, from October 2009 to March 2010.
Subjects
The study included 593 subjects (260 males, 333 females), with a mean age of 38.6 ± 12.9 years, ranging from 18-60 years. We recruited 315 MDD patients and 278 healthy controls, with no person declining to participate. The protocols were described to subjects, and written informed consent was obtained from each subject [27] .
Inclusion criteria: patients from central China with major depression, who met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition [28] criteria. Additionally, a minimum baseline score of 15 on the 17-item Hamilton Rating Scale for depression. To reduce the influence of population stratification in gene frequencies, all participants in this study were from the Chinese Han population in Henan Province, located in central China.
Exclusion criteria: patients with substance abuse, severe organic disorder, organic brain disease or any concomitant major psychiatric disorder were excluded following clinical interviews. Healthy controls were recruited from the same region of the Chinese Han population as MDD patients. Subjects with a past or present psychiatric disorder, or a positive family history of a psychiatric disorder were excluded.
Methods
ADCY9 DNA extraction and PCR assay
Genomic DNA was extracted from ethylenediamine tetraacetic acid-treated venous blood samples obtained from the elbow, by standard techniques using a DNA extraction kit (Wizard Genomic DNA purification kit; Promega, Wisconsin, USA). Primer details are shown in (Figure 1 ).
ADCY9 post-PCR ligase detection reaction genotyping assay
Genotyping was carried out in a final volume of 10 μL, containing 1 μL PCR mixture, 6.95 μL H 2 O, 0.05 μL ligase, 1 μL probe mix and 1 μL buffer. After an initial denaturation at 95°C for 2 minutes, there were 35 cycles of denaturation at 94°C for 30 seconds, with annealing and extension at 60°C for 20 minutes. Ligase detection reaction products were used for allele discrimination.
ADCY9 allele discrimination
Ligase detection reaction products were separated on 6% denaturing polyacrylamide gels using an ABI 377 automated sequencer (Applied Biosystems Incorporation, Maryland, USA). Genescan TM 672 software (Applied Biosystems Incorporation) collected data, corrected the line of electrophoresis and measured different fragments.
Genemapper software was used to analyze genotype distributions data (Figure 2 ). 
